FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
FEMASYS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.63−0.02 (-1.21%)
Close on Oct 19, 2026
- Market cap
- $5.47M
- P/E (TTM)
- –
- Dividend yield
- –
FEMASYS INC revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $324.63K | $367.33K | $378.39K | $336.59K | $337.31K | $341.26K | $318.43K | $262.46K | $221.48K | – | $213.11K | $244.36K | 97.8% | -3.8% |
| International [Member] | $7.20K | $57.56K | $435.00K | $392.80K | $71.96K | $0 | $263.15K | $292.45K | $0 | – | $0 | $0 | 2.2% | -90.0% |
From the segment and revenue-disaggregation notes of Femasys's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.